RIL
ANIK icon

Rothschild Investment LLC’s Anika Therapeutics ANIK Stock Holding History

Rothschild Investment LLC’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75K Buy
188
+66
+54% +$978 ﹤0.01% 2621
2026
Q1 		$1.77K Buy
122
+82
+205% +$952 ﹤0.01% 2614
2025
Q4 		$384 Buy
+40
New +$383 ﹤0.01% 2994
2025
Q2 		– Sell
-10
Closed -$150 – 3025
2025
Q1 		$150 Sell
10
-115
-92% -$1.91K ﹤0.01% 2901
2024
Q4 		$2.06K Hold
125
– – ﹤0.01% 1782
2024
Q3 		$3.09K Sell
125
-150
-55% -$3.89K ﹤0.01% 1493
2024
Q2 		$6.97K Hold
275
– – ﹤0.01% 1158
2024
Q1 		$6.99K Hold
275
– – ﹤0.01% 1101
2023
Q4 		$6.23K Buy
+275
New +$5.69K ﹤0.01% 1058

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IP
Indivisible Partners Clearwater, Florida $1.77B AUM
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Rothschild Investment LLC's ANIK Position: Q2 2026 in Review

Rothschild Investment LLC increased its Anika Therapeutics (ANIK) stake by 54% in Q2 2026, buying an estimated $978 and bringing the position to 188 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2621.

Rothschild Investment LLC first reported a position in ANIK in Q4 2023 and has held it in 9 quarters since. The position peaked at $6.99K in Q1 2024. 43 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Rothschild Investment LLC held 188 shares of Anika Therapeutics worth $2.75K as of Q2 2026.
  • Rothschild Investment LLC bought 66 Anika Therapeutics shares in Q2 2026, an estimated $978.
  • Anika Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2621 holding.
  • Rothschild Investment LLC first reported a position in Anika Therapeutics in Q4 2023 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Anika Therapeutics position peaked at $6.99K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.